Strategies for the prevention of mother-to-child transmission (PMTCT) of HIV have undergone considerable evolution based on scientific evidence, both at global and local levels. Because of the rapid expansion of the HIV epidemic among the heterosexual population, and the relatively advanced mother and child health infrastructure, Thailand has been …
This is a 3D animation video clip to teach Thai children who have above 10 years old to understand that if they going to be teenager, how to have safe sex, pregnancy prevention, and sexually transmitted diseases prevention.
BANGKOK—The old saying, “You are what you eat,” doesn’t apply that well to Atachai Phunkron. It’s more about what he wears. Who would have thought a nondescript lab coat could change his life? Just ask him about it and watch him beam.
“PrEPARING ASIA: A new direction for HIV prevention among MSM in Asia” is a regional dialogue preparing the future roll-out of pre-exposure prophylaxis (PrEP) for self-identified gay men and other men who have sex with men (MSM) in Asia. Organized by APCOM with the support from UNAIDS and WHO, the dialogue will bring in representatives of
The success of Adam’s Love and TemanTeman.org in Thailand, Indonesia and Malaysia, we are proud to expand Adam’s Love program to East Asia and launch Adam’s Love in Taiwan
In August, Adam’s Love will launch Adam’s Love Taiwan, its fourth country-specific HIV outreach campaign targeting at-risk populations through its unique online edutainment approach that combines educational HIV resources with videos and social media posts from national celebrities.
Thirty years ago, Dr. Praphan Phanuphak diagnosed the first three cases of HIV in Thailand. In 1989, he co-founded the Thai Red Cross AIDS Research Centre (TRC-ARC), and currently serves as its director.
A major international clinical trial has provided the strongest evidence yet that people infected with H.I.V., the virus that causes AIDS, should get treated as soon as possible, even if they are feeling well, to ward off serious illness and fatal complications in future years. The finding raises the powerful moral question of whether global and national organizations can find the will
What is the START study? The START (“Strategic Timing of AntiRetroviral Treatment”) study is a randomized, controlled clinical trial designed to more clearly define the optimal time for HIV- infected individuals to begin antiretroviral therapy. The trial enrolled healthy, asymptomatic, HIV-infected people whose level of CD4+ T cells—a measure of immune system health—exceeded 500